UDG acquires specialist and scientific PR agencies

8 July 2014

UDG Healthcare acquires specialist healthcare and scientific public relations agencies

UDG Healthcare plc, a leading international provider of healthcare services, announces that it has acquired the specialist healthcare and scientific public relations (PR) businesses, Galliard and Nyxeon (MFRHRC Holdings Limited).

MFRHRC Holdings Limited is being acquired for £6.5 million net cash on completion with an additional £6.5 million of the consideration payable based on achievement of agreed profit targets over the next 3 years. It is estimated that the value of the gross assets being acquired will be

£5.0 million. These assets generated annual revenues of £5.57 million and a profit after tax of

£1.73 million in the year to December 2013.

The acquisition is expected to be immediately earnings enhancing.

Transaction highlights:

· Galliard and Nyxeon add capabilities in data driven healthcare and scientific public relations to UDG Healthcare's market leading, global healthcare communications business Ashfield Healthcare Communications.

· The businesses complement the existing services delivered by Ashfield Healthcare Communications adding both scale and depth to core healthcare communications services, in addition to specialist expertise in scientific PR.

Galliard / Nyxeon:

· Established in 2000, Galliard is an award-winning agency with deep experience in the communication of science to healthcare professionals, caregivers, policy makers and consumers.

· Galliard and Nyxeon are both headquartered in London and employ 33 people who provide services to global pharmaceutical companies, healthcare-related organisations and charities.

· The specialist PR services offered by the agencies include; media relations, issues management, scientific & medical education, corporate and employee communications.

Commenting on the announcement, Liam FitzGerald, Chief Executive of UDG Healthcare plc said:

"We are delighted to announce the acquisition of Galliard and Nyxeon which add strong scientific public relations capabilities to the services we already deliver to our clients. This purchase is fully aligned with our global growth strategy of extending the range of services we offer in high value multichannel healthcare communications and follows the successful acquisitions of InforMed, Watermeadow and more recently Knowledgepoint360."

ENDS

For Enquiries:

Investors and Analysts: Media:

Alan Ralph, CFO Greg Lawless/Lisa Kavanagh/Claire Turvey

David Marshall, CFO

UDG Healthcare plc Powerscourt

Tel: +353 1 463 2300 Tel: +44 207 250 1446

Notes to Editors:

About UDG Healthcare plc:

Listed on the London Stock Exchange, UDG Healthcare plc is a leading international provider of services to healthcare manufacturers and pharmacies, with operations in 22 countries including the US, UK, Ireland and Germany.

The Group operates across three divisions: Ashfield Commercial and Medical Services, Supply Chain Services and Sharp Packaging Services.

Ashfield Commercial and Medical Services is a global leader in the provision of outsourced multi-channel communications to healthcare professionals and patients. Ashfield has operations in major markets including continental Europe, the UK, North America and a presence in South America and Asia. The division provides sales teams, telesales, nurse educators, medical information, healthcare communications and event management services to healthcare companies in 22 countries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle.

Supply Chain Services includes the United Drug Supply Chain Services and the Aquilant Specialist Healthcare Services businesses. United Drug Supply Chain Services is the largest pharmaceutical wholesaler in the island of Ireland. It is also the leading pre-wholesaler in Ireland and has achieved the No.1 position in the UK through its joint venture business UniDrug Distribution Group. The division provides logistics services to healthcare companies, pharmacies and hospitals in the UK and Ireland. Aquilant Specialist Healthcare Services is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in Ireland and the UK.

Sharp Packaging Services is a leading international provider of pharmaceutical contract packaging and clinical trials materials services with facilities in the US, UK, Dutch and Belgian markets.

For more information go to: www.udghealthcare.com.